logoTry Persana

Reverie Labs - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Reverie Labs including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Reverie Labs company logo

Engineering next generation kinase inhibitors with computation.

Reverie Labs is pioneering the application of AI/ML tools for drug discovery, specifically in kinase inhibitors.

HeadquartersCambridge, United States
Team size1-50
Founded2017

What is Reverie Labs? - Company Overview & Details

Reverie Labs is Reverie Labs is pioneering the application of AI/ML tools for drug discovery, specifically in kinase inhibitors. Founded in 2017, the company is headquartered in Cambridge, United States.

Who Founded Reverie Labs?

Reverie Labs was founded by Jonah Kallenbach, Ankit Gupta.

Who are the Key Executives at Reverie Labs? - Leadership Team

Reverie Labs is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Reverie Labs

Jonah KallenbachCEO

Chief Technology Officer (CTO) of Reverie Labs

Ankit GuptaCTO

About Jonah Kallenbach - CEO of Reverie Labs

Jonah Kallenbach serves as the Chief Executive Officer of Reverie Labs, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Reverie Labs Company Details & Key Information

Where is Reverie Labs located?

Reverie Labs is headquartered in Cambridge, United States.

How many employees does Reverie Labs have?

Reverie Labs has 1-50 employees.

When was Reverie Labs founded?

Reverie Labs was founded in 2017.

Reverie Labs Official Website

How much funding has Reverie Labs raised?

Reverie Labs has raised $32 Million across 3 funding rounds. The most recent funding was completed on 2021-02-03.

Funding Overview

Reverie Labs raised $25M in Series A round led by Ridgeback Capital Investments.

$32 Million
Total Funding Raised
3
Funding Rounds
2021-02-03
Latest Round

Reverie Labs Funding History

Series A
2021-02-03
$25 Million

Who are the key investors in Reverie Labs?

Reverie Labs is backed by 1 key investors including Ridgeback Capital. These investors focus on sectors.

Reverie Labs Investor Overview

1
Key Investors
0
Focus Areas
0
Notable Investments

Complete List of Reverie Labs Investors

Ridgeback Capital

What sectors do Reverie Labs investors focus on?

The investors backing Reverie Labs primarily focus on sectors.

Featured Investor: Ridgeback Capital

Ridgeback Capital

Notable Investments:

What are Reverie Labs's future plans?

Reverie Labs Focus on integrating AI/ML technologies with Ginkgo Bioworks to enhance drug discovery processes.

Reverie Labs Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does Reverie Labs face?

Reverie Labs has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for Reverie Labs

1

Maintaining innovation under competition

2

Scaling technology effectively

What opportunities does Reverie Labs have?

Reverie Labs has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for Reverie Labs

1

Expanding drug discovery capabilities

2

Strengthening collaborations within the biotech industry

Reverie Labs Strategic Position Summary

Key Focus Areas

Reverie Labs is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about Reverie Labs?

Reverie Labs has 2 recent news updates covering key business developments and market activities.

Reverie Labs News Overview

2
Recent Articles
Active
Media Coverage
2024-02-27
Latest Update

What is Reverie Labs in the news for?

Reverie Labs is currently featured in news for Ginkgo Bioworks acquired Reverie Labs Inc. on Jan 28th '24. and other significant business developments.

Recent News Articles About Reverie Labs

Article 1
2024-02-27

Ginkgo Bioworks acquired Reverie Labs Inc. on Jan 28th '24.

Ginkgo Bioworks acquires Reverie Labs platform, enhancing AI-driven drug discovery capabilities.

prnewswire.com
Read News
Article 2
2021-02-03

Reverie Labs Inc. received financing of $25M in Series A on Feb 3rd '21.

Reverie Labs raised $25M in Series A financing to advance its drug discovery platform.

prnewswire.com
Read News

Reverie Labs FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Reverie Labs including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Reverie Labs Questions & Answers - Company Information

Q1

What is Reverie Labs?

Reverie Labs is pioneering the application of AI/ML tools for drug discovery, specifically in kinase inhibitors.

Q2

Who founded Reverie Labs?

Reverie Labs was founded by Jonah Kallenbach, Ankit Gupta.

Q3

Who is the CEO of Reverie Labs?

The CEO of Reverie Labs is Jonah Kallenbach. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Reverie Labs raised?

Reverie Labs has raised a total of $$32 Million across 3 funding rounds. The most recent funding was completed on 2021-02-03.

Q5

Who are the investors in Reverie Labs?

Reverie Labs's key investors include Ridgeback Capital.

Q6

Where is Reverie Labs headquartered?

Reverie Labs is headquartered in Cambridge, United States.

Q7

When was Reverie Labs founded?

Reverie Labs was founded in 2017.

Q8

How many employees does Reverie Labs have?

Reverie Labs has 1-50 employees.

Q9

What is Reverie Labs's official website?

You can visit Reverie Labs's official website at https://www.reverielabs.com.

Q10

What was Reverie Labs's latest funding round?

Reverie Labs's latest funding round was a Series A round of $$25 Million completed on 2021-02-03.

Q11

Who is founder?

Jonah Kallenbach

Q12

Who is cto?

Ankit Gupta

Q13

What does the company do?

Reverie Labs is pioneering the application of AI/ML tools for drug discovery, specifically in kinase inhibitors.

Q14

How much funding?

$32 Million

Q15

Latest funding date?

2021-02-03

Q16

Who are the investors?

Ridgeback Capital

Q17

What are the challenges?

Maintaining innovation under competition Scaling technology effectively

Q18

What are the opportunities?

Expanding drug discovery capabilities Strengthening collaborations within the biotech industry

Q19

Latest news?

Ginkgo Bioworks acquires Reverie Labs platform, enhancing AI-driven drug discovery capabilities. Reverie Labs raised $25M in Series A financing to advance its drug discovery platform.

More Information About Reverie Labs

For additional details about Reverie Labs, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.